showed a trendp=0.079
Participants treated with lipid lowering drugs with dyslipidaemia (n=10/61) showed a trend for a higher capillary length than participants without dyslipidaemia (p=0.079).
Participants treated with lipid lowering drugs with dyslipidaemia (n=10/61) showed a trend for a higher capillary length than participants without dyslipidaemia (p=0.079).